Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Suitability depends on individual medical assessment
(Learn more about heart monitoring on the Long-Term Monitoring page)
A 75-year-old man with type 2 diabetes was switched from 14 mg daily of oral semaglutide (Rybelsus) to subcutaneous tirzepatide
Face-to-face access to GLP-1 specialists allows treatment adjustments based on direct observation rather than virtual check-ins
To identify newer evidence, a search was conducted on PubMed for RCTs, systematic reviews and meta-analyses published in English between 28 January 2018 and 13 June 2022
US$ 20.88
US$ 22.34
US$ 23.72
US$ 26.16
US$ 20.62
US$ 28.66
US$ 28.63
